Literature DB >> 7579146

Benzodiazepine antagonist flumazenil reduces hippocampal epileptiform activity.

P Polc1, S S Jahromi, G Facciponte, M R Pelletier, L Zhang, P L Carlen.   

Abstract

We examined the effects of the benzodiazepine antagonist, flumazenil, on epileptiform discharges evoked in the hippocampal CA1 region in vitro. Application of 100 nM flumazenil did not affect normal synaptic responses; however, flumazenil did depress epileptiform discharges induced by 8 mM [K+]o. Epileptiform discharges induced by the GABAA channel antagonist picrotoxin or by the K+ channel blocker 4-aminopyridine were unaffected. Application of the high-affinity, low-efficacy benzodiazepine partial inverse agonist, Ro 19-4603, blocked the anticonvulsant effect of flumazenil, indicating that this action of flumazenil is mediated at a benzodiazepine binding site located on the GABAA receptor. A likely explanation of the present results is that flumazenil antagonizes the action of an endogenous benzodiazepine inverse agonist, which is released during epileptiform discharges evoked in high K+ ACSF.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579146     DOI: 10.1097/00001756-199507310-00021

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  2 in total

1.  Rats with different thresholds to clonic convulsions induced by DMCM differ in the binding of [3H]-MK-801 and [3H]-ouabain in the membranes of brain regions.

Authors:  Marcos Brandão Contó; José Gilberto Barbosa de Carvalho; Marco Antonio Campana Venditti
Journal:  Neurochem Res       Date:  2012-03-01       Impact factor: 3.996

2.  Pharmacological plasticity of GABA(A) receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy.

Authors:  Claire Leroy; Pierrick Poisbeau; A Florence Keller; Astrid Nehlig
Journal:  J Physiol       Date:  2004-03-19       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.